Vanda Pharmaceuticals
VNDA
#7546
Rank
โ‚ฌ0.34 B
Marketcap
5,80ย โ‚ฌ
Share price
-2.70%
Change (1 day)
28.89%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2025 (TTM): -โ‚ฌ0.11 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ0.21 Billion. In 2024 the company made an earning of -โ‚ฌ34.46 Million a decrease over its 2023 earnings that were of -โ‚ฌ11.83 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ0.11 Billion210.87%
2024 -โ‚ฌ34.46 Million191.43%
2023 -โ‚ฌ11.83 Million-320.45%
2022 โ‚ฌ5.36 M-84.99%
2021 โ‚ฌ35.73 M54.8%
2020 โ‚ฌ23.08 M19.42%
2019 โ‚ฌ19.33 M4.93%
2018 โ‚ฌ18.42 M-228.6%
2017 -โ‚ฌ14.33 Million-8.98%
2016 -โ‚ฌ15.74 Million-53.79%
2015 -โ‚ฌ34.06 Million-30.18%
2014 -โ‚ฌ48.78 Million173.08%
2013 -โ‚ฌ17.87 Million-25.33%
2012 -โ‚ฌ23.93 Million163.61%
2011 -โ‚ฌ9.08 Million-221.15%
2010 โ‚ฌ7.49 M-124.53%
2009 -โ‚ฌ30.54 Million-29.44%
2008 -โ‚ฌ43.28 Million-36.2%
2007 -โ‚ฌ67.84 Million21.81%
2006 -โ‚ฌ55.69 Million170.55%
2005 -โ‚ฌ20.59 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
โ‚ฌ13.91 B-13,658.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
โ‚ฌ19.07 B-18,683.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ27.45 B-26,852.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ6.80 B-6,733.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ10.04 B-9,887.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-โ‚ฌ2.38 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ19.56 B-19,167.83%๐Ÿ‡บ๐Ÿ‡ธ USA